Clinical Trial Update: 18F-FMISO PET Guided Dose Escalation in Nasopharyngeal Carcinoma - a Feasibility and Planning Study [NA]

View source ↗

Summary

This clinical trial update reports completion of a feasibility and planning study that uses 18F-FMISO PET imaging to guide dose escalation in nasopharyngeal car…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Drugs mentioned

• 18F-FMISO (fluoromisonidazole)

Snippet

Sponsor: National Cancer Centre, Singapore | Conditions: Nasopharyngeal Carcinoma | NA | Status: COMPLETED